Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v9-FR
Language English French
Date Updated 2019-09-17 2019-09-16
Drug Identification Number 02309238 02309238
Brand name BREVIBLOC PREMIXED INJECTION BREVIBLOC PREMIXED INJECTION
Common or Proper name BREVIBLOC PREMIXED INJECTION BREVIBLOC PREMIXED INJECTION
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients ESMOLOL HYDROCHLORIDE ESMOLOL HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250 mL Intravia Container 250 mL Intravia Container
ATC code C07AB C07AB
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-08-16 2019-08-16
Actual start date 2019-08-16 2019-08-16
Estimated end date 2019-09-16 2019-09-16
Actual end date 2019-09-16 2019-09-16
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Very limited stock. Product on allocation. We have Brevibloc 10mg/mL VIALS available which can be reconstituted as per the customer requirement. For questions or concerns contact Baxter customer care (1.888.719.9955) or your local representative. Very limited stock. Product on allocation. We have Brevibloc 10mg/mL VIALS available which can be reconstituted as per the customer requirement. For questions or concerns contact Baxter customer care (1.888.719.9955) or your local representative.
Health Canada comments